相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer management
Matthew C. Phillips et al.
NANOMEDICINE (2022)
Modulation of the tumor microenvironment by armed vesicular stomatitis virus in a syngeneic pancreatic cancer model
Sijia Tang et al.
VIROLOGY JOURNAL (2022)
Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice
Akito Tsuruta et al.
MOLECULAR CANCER RESEARCH (2022)
Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity
Jin-Yan Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Combined oncolytic adenovirus carrying MnSOD and mK5 genes both regulated by survivin promoter has a synergistic inhibitory effect on gastric cancer
Shan-Shan Liu et al.
NEOPLASMA (2022)
Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective
Egle Ramelyte et al.
CANCER CELL (2021)
Gastric organoids-an in vitro model system for the study of gastric development and road to personalized medicine
Therese Seidlitz et al.
CELL DEATH AND DIFFERENTIATION (2021)
miR-375-and miR-1-Regulated Coxsackievirus B3 Has No Pancreas and Heart Toxicity But Strong Antitumor Efficiency in Colorectal Carcinomas
Ahmet Hazini et al.
HUMAN GENE THERAPY (2021)
Oncolytic Herpes Simplex Virus Type 2 Can Effectively Inhibit Colorectal Cancer Liver Metastasis by Modulating the Immune Status in the Tumor Microenvironment and Inducing Specific Antitumor Immunity
Wen Zhang et al.
HUMAN GENE THERAPY (2021)
Identification of in vitro and in vivo oncolytic effect in colorectal cancer cells by Orf virus strain NA1/11
Daxiang Chen et al.
ONCOLOGY REPORTS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Evaluation of the oncolytic property of recombinant Newcastle disease virus strain R2B in 4T1 and B16-F10 cells in-vitro
Narayan Ramamurthy et al.
RESEARCH IN VETERINARY SCIENCE (2021)
Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer
Shuichi Matsumura et al.
Oncotarget (2021)
Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
Ahmet Hazini et al.
VIRUSES-BASEL (2021)
A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer
Na Wang et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer
Shuxin Sun et al.
CANCER LETTERS (2021)
β-Adrenergic Receptor Inhibitor and Oncolytic Herpesvirus Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects on Colorectal Cancer
Jiali Hu et al.
FRONTIERS IN PHARMACOLOGY (2021)
The efficacy and safety of oncolytic viruses in the treatment of intermediate to advanced solid tumors: a systematic review and meta-analysis
Peng Gao et al.
TRANSLATIONAL CANCER RESEARCH (2021)
Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma
Shoh Yajima et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Oncolytic Virotherapy: From Bench to Bedside
Ludi Yang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
Tomoya Kato et al.
ONCOLOGY LETTERS (2021)
Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control
Dafne C. A. Quixabeira et al.
FRONTIERS IN IMMUNOLOGY (2021)
Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial
Bo Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus with MEK Inhibitor Trametinib in Some BRAF or KRAS-Mutated Colorectal or Lung Carcinoma Models
XuSha Zhou et al.
VIRUSES-BASEL (2021)
The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
Joshua D. Bernstock et al.
VIRUSES-BASEL (2021)
β-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through STAT3 activation in gastric cancer
Jiali Hu et al.
CELL AND BIOSCIENCE (2021)
Oncolytic herpes virus G47Δ injected into tongue cancer swiftly traffics in lymphatics and suppresses metastasis
Toshihiro Uchihashi et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy
Mitra Nair et al.
CANCERS (2021)
A dual cancer-specific recombinant adenovirus suppresses the growth of liver cancer cells in vivo and in vitro
Yufei Tian et al.
ANTI-CANCER DRUGS (2020)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study
Devalingam Mahalingam et al.
CLINICAL CANCER RESEARCH (2020)
MiR-375-mediated suppression of engineered coxsackievirus B3 in pancreatic cells
Markian Pryshliak et al.
FEBS LETTERS (2020)
Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells
Sara L. Seegers et al.
JOURNAL OF VIROLOGY (2020)
Recommendations for the nomenclature of enteroviruses and rhinoviruses
P. Simmonds et al.
ARCHIVES OF VIROLOGY (2020)
Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
Gang Meng et al.
BRITISH JOURNAL OF CANCER (2020)
Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer
Yanghee Woo et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)
Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus
Mark S. Ferguson et al.
MOLECULAR THERAPY (2020)
Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade
Shinsuke Nakao et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
Jing Ma et al.
CELL DEATH & DISEASE (2020)
ERK/MAPK signalling pathway and tumorigenesis
Yan-Jun Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
oHSV2 Can Target Murine Colon Carcinoma by Altering the Immune Status of the Tumor Microenvironment and Inducing Antitumor Immunity
Wen Zhang et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
Ufuk Degirmenci et al.
CELLS (2020)
Recent advances of oncolytic virus in cancer therapy
Moumita Mondal et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses
Guan Wang et al.
NATURE COMMUNICATIONS (2020)
Novel Oncolytic Virus Armed with Cancer Suicide Gene and Normal Vasculogenic Gene for Improved Anti-Tumor Activity
Su-Nam Jeong et al.
CANCERS (2020)
Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis
Shanawaz M. Ghouse et al.
FRONTIERS IN ONCOLOGY (2020)
Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer
Kotaro Sugawara et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer
Takeshi Koujima et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
Noemi Garcia-Romero et al.
CELLS (2020)
Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer
Masakazu Hamada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Clinical Application of Oncolytic Viruses: A Systematic Review
Mary Cook et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Boosting Replication and Penetration of Oncolytic Adenovirus by Paclitaxel Eradicate Peritoneal Metastasis of Gastric Cancer
Wataru Ishikawa et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation
Tomoharu Yamada et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade
Yang Liu et al.
CELL DEATH & DISEASE (2020)
Lonidamine potentiates the oncolytic efficiency of M1 virus independent of hexokinase 2 but via inhibition of antiviral immunity
Jing Cai et al.
CANCER CELL INTERNATIONAL (2020)
Orthotopic hepatocellular carcinoma: molecular imaging-monitored intratumoral hyperthermia-enhanced direct oncolytic virotherapy
Jingjing Song et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2019)
Extremely Low Organ Toxicity and Strong Antitumor Activity of miR-34-Regulated Oncolytic Coxsackievirus B3
Yang Jia et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma
Gang Meng et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
M51R and Delta-M51 matrix protein of the vesicular stomatitis virus induce apoptosis in colorectal cancer cells
Zahra Gray et al.
MOLECULAR BIOLOGY REPORTS (2019)
A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression
Susanne G. Warner et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth
Zhiwen Wu et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma
Haoyu Deng et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer
Margaret L. Axelrod et al.
CLINICAL CANCER RESEARCH (2019)
Optimizing the outcomes of pancreatic cancer surgery
Oliver Strobel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Selectins in cancer immunity
Lubor Borsig
GLYCOBIOLOGY (2018)
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer
Yoshiki Hirooka et al.
BMC CANCER (2018)
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial
Derek J. Jonker et al.
CLINICAL COLORECTAL CANCER (2018)
Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma
Ahmet Hazini et al.
HUMAN GENE THERAPY (2018)
Oncolytic Reovirus Inhibits Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in a TLR3-Dependent Manner
Yuki Katayama et al.
JOURNAL OF IMMUNOLOGY (2018)
Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
Jacob M. Ricca et al.
MOLECULAR THERAPY (2018)
Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer
Amanda O. Salzwedel et al.
Oncotarget (2018)
Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro
Andra Tilgase et al.
JOURNAL OF CANCER (2018)
A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Devalingam Mahalingam et al.
CANCERS (2018)
What's New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives
Giuseppe Tirino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma
Sarah Abdullahi et al.
JOURNAL OF VIROLOGY (2018)
A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11
Beibei Wang et al.
ANTICANCER RESEARCH (2018)
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Oncolytic virus immunotherapy: future prospects for oncology
Junaid Raja et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K. Bommareddy et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Newcastle disease virus mediates pancreatic tumor rejection via NK cell activation and prevents cancer relapse by prompting adaptive immunity
Theresa Schwaiger et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update
Sebastien A. Felt et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus
Sebastien A. Felt et al.
JOURNAL OF VIROLOGY (2017)
Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma
Bingbing Dai et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Replication and Oncolytic Activity of an Avian Orthoreovirus in Human Hepatocellular Carcinoma Cells
Robert A. Kozak et al.
VIRUSES-BASEL (2017)
ING4 expressing oncolytic vaccinia virus promotes anti-tumor efficiency and synergizes with gemcitabine in pancreatic cancer
Yinfang Wu et al.
ONCOTARGET (2017)
Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity
Liu Ying et al.
ONCOTARGET (2017)
Evolutionary cancer-favoring engineered vaccinia virus for metastatic hepatocellular carcinoma
So Young Yoo et al.
ONCOTARGET (2017)
Oncolytic Viruses in Cancer Treatment A Review
Sean E. Lawler et al.
JAMA ONCOLOGY (2017)
Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
Emma Eriksson et al.
CLINICAL CANCER RESEARCH (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer
Kyung Hee Jung et al.
CANCER LETTERS (2017)
The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma
Carmela Passaro et al.
ONCOTARGET (2016)
Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports
Peteris Alberts et al.
APMIS (2016)
A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer (vol 148, pg 489, 2014)
Sepideh Gholami et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
Antoni Ribas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route
Zhen Wang et al.
ONCOTARGET (2016)
Antibody-Mediated Phosphatidylserine Blockade Enhances the Antitumor Responses to CTLA-4 and PD-1 Antibodies in Melanoma
Bruce D. Freimark et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Antitumour actions of interferons: implications for cancer therapy
Belinda S. Parker et al.
NATURE REVIEWS CANCER (2016)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer
Pavani Chalasani et al.
CANCER MEDICINE (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta
Jiani Wang et al.
CANCER CELL INTERNATIONAL (2014)
Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer
Raghunadharao Digumarti et al.
LUNG CANCER (2014)
Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers
Yuan Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer
Toshiaki Tsuji et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity
Toshimitsu Ohashi et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Mounting a strategic offense: fighting tumor vasculature with oncolytic viruses
Fernando A. Angarita et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer
T. T. Sahin et al.
CANCER GENE THERAPY (2012)
Ablation of Perivascular Hepatic Malignant Tumors with Irreversible Electroporation
T. Peter Kingham et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
Mark S. Ferguson et al.
ADVANCES IN VIROLOGY (2012)
Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice
Y. Kulu et al.
CANCER GENE THERAPY (2009)
Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61
Kazuhiko Kurozumi et al.
MOLECULAR THERAPY (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow
Caroline J. Breitbach et al.
MOLECULAR THERAPY (2007)
Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptide
Manish Aghi et al.
CANCER RESEARCH (2007)
Oncolytic adenovirus-mediated E1A gene therapy induces tumor-cell apoptosis and reduces tumor angiogenesis leading to inhibition of hepatocellular carcinoma growth in animal model
Zhenmin Ye et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2006)
Heparan sulfates and coxsackievirus-adenovirus receptor:: Each one mediates coxsackievirus B3PD infection
AE Zautner et al.
JOURNAL OF VIROLOGY (2003)
分享论文
